Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea

The U.S. Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept...

FDA Approves Opuviz (aflibercept-yszy), an Interchangeable Biosimilar to Eylea

The U.S. Food and Drug Administration (FDA) has approved Opuviz (aflibercept-yszy), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept...

FDA Approves Benlysta (belimumab) Autoinjector for Children with Systemic Lupus Erythematosus

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a 200 mg subcutaneous route of administration of Benlysta...

FDA Grants Accelerated Approval for Imdelltra (tarlatamab-dlle) for the Treatment of Extensive-Stage Small Cell Lung Cancer

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Imdelltra™ (tarlatamab-dlle) for the treatment...

Stroke Rates Are Rising, Especially Among the Young

The rate at which Americans under the age of 65 suffered a stroke rose by about 15% between 2011 and 2022, new government data shows.That was true even...

Parental Legal System Involvement Linked to Adverse Child Mental Health

Parental legal system involvement may negatively impact child mental health, according to a study published online May 23 in Pediatrics.Lilian G. Bravo,...

Few Adults With Moderate, Severe Asthma Receive Recommended Inhaler Regimen

Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended Single Maintenance and Reliever Therapy (SMART) inhaler...

2024 ASCO Annual Meeting to Focus on Clinical Cancer Research Impacting Patient Care

 The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held May 31 to June 4, 2024, in Chicago and online.The theme of this...

Socioeconomic Status Transitions Tied to Dementia Risk

Upward and downward socioeconomic status (SES) transitions are associated with the risk for dementia and the length of dementia-free periods during the...

Costs, Side Effects Drive Folks to Quit New Weight-Loss Meds

Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from...

'Moving Forward': Battling Parkinson's, He's Rowing His Way to Paralympic Games

For decades, Todd Vogt has been dedicated to the sport of rowing, believing he was in peak physical condition. Then, a series of symptoms began to emerge,...

CDC Reports Second Dairy Worker Infected With Bird Flu

A second case of bird flu has been detected in another dairy worker, this time in Michigan, U.S. health officials reported Wednesday.The first case was...

New Results From Rilzabrutinib Phase 2 Study Show Potential to be First Advanced Oral Treatment for Moderate-to-Severe Asthma

Paris, May 22, 2024. Encouraging results from a phase 2 study showed that treatment with oral rilzabrutinib at both high dose and low doses led to a numerical...

GSK Announces Positive Results from Phase III Severe Asthma Trials of Depemokimab

GSK plc (LSE/NYSE: GSK) today announced positive headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed the efficacy and...

Hospira Inc. Issues Voluntary Recall for Buprenorphine HCl Injection Carpuject Units and Labetalol HCl Injection Carpuject Units Due to Potential for Incomplete Crimp Seals

May 21, 2024 - NEW YORK, NY., Hospira, Inc., a Pfizer company (“Pfizer”), is voluntarily recalling the lots listed in the table below of Buprenorphine...

Does It Matter What You Eat or Drink Before Bed?

If you suddenly find yourself craving food or drink right before you head to bed, one expert suggests you steer clear of big meals and caffeine. "From...

Read more news...

Recently Added

Recently added consumer and prescribing information: Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Yesafili Yesafili (aflibercept-jbvf) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...
  • Opuviz Opuviz (aflibercept-yszy) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...
  • Imdelltra Imdelltra (tarlatamab-dlle) is a first-in-class, bispecific delta-like ligand 3 (DLL3)-directed CD3 T cell engager indicated for the...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development